Hillsdale Investment Management Inc. Takes $5.28 Million Position in Nu Skin Enterprises, Inc. $NUS

Hillsdale Investment Management Inc. bought a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 660,660 shares of the company’s stock, valued at approximately $5,279,000.

Several other large investors have also modified their holdings of NUS. Vanguard Group Inc. raised its holdings in Nu Skin Enterprises by 4.9% in the 1st quarter. Vanguard Group Inc. now owns 4,133,109 shares of the company’s stock valued at $30,006,000 after buying an additional 193,038 shares during the period. Prescott Group Capital Management L.L.C. raised its stake in shares of Nu Skin Enterprises by 24.4% in the 2nd quarter. Prescott Group Capital Management L.L.C. now owns 1,734,608 shares of the company’s stock valued at $13,860,000 after acquiring an additional 340,000 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Nu Skin Enterprises by 7.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock worth $9,582,000 after acquiring an additional 88,088 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Nu Skin Enterprises by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 1,175,049 shares of the company’s stock worth $9,391,000 after purchasing an additional 21,276 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Nu Skin Enterprises by 47.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company’s stock valued at $7,640,000 after purchasing an additional 336,807 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Performance

Shares of NUS opened at $10.01 on Friday. The stock has a 50-day simple moving average of $10.92 and a 200-day simple moving average of $9.71. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.38 and a current ratio of 2.01. Nu Skin Enterprises, Inc. has a 1 year low of $5.32 and a 1 year high of $14.62. The stock has a market capitalization of $487.79 million, a PE ratio of 4.98 and a beta of 0.97.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.30 by $0.04. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. The company had revenue of $364.21 million during the quarter, compared to the consensus estimate of $374.20 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS. Q4 2025 guidance at 0.250-0.350 EPS. On average, analysts predict that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Friday, November 28th will be paid a $0.06 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.24 dividend on an annualized basis and a yield of 2.4%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 11.01%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on NUS shares. Zacks Research upgraded Nu Skin Enterprises to a “hold” rating in a research report on Tuesday, August 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Wednesday, October 8th. Finally, Wall Street Zen downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 15th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus price target of $7.00.

Check Out Our Latest Research Report on NUS

Insiders Place Their Bets

In other news, EVP Chayce David Clark sold 20,000 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total transaction of $239,400.00. Following the completion of the transaction, the executive vice president directly owned 233,140 shares of the company’s stock, valued at approximately $2,790,685.80. This represents a 7.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Daniel W. Campbell sold 23,391 shares of the firm’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $12.10, for a total value of $283,031.10. Following the sale, the director directly owned 53,375 shares in the company, valued at $645,837.50. This trade represents a 30.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 58,926 shares of company stock valued at $711,364 in the last ninety days. Insiders own 2.00% of the company’s stock.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

See Also

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.